XPR – Lifestyle Demo
Author:
CorMedix, Inc.
Cormedix Therapeutics to Participate in two Upcoming Investor Conferences
May 15, 2026
Cormedix Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update
May 14, 2026
CorMedix Therapeutics to Report First Quarter 2026 Financial Results and Provide a Corporate Update on May 14, 2026
May 5, 2026
CorMedix Therapeutics Announces Positive Topline Results from Phase III ReSPECT Trial Assessing REZZAYO® for the Prophylaxis of Invasive Fungal Diseases in Allogeneic Hematopoietic Stem Cell Transplantation Patients
April 27, 2026
CorMedix to Participate in Needham Virtual Healthcare Conference
April 7, 2026